Derivatives of pyridone and the use of them

Details Derivatives of pyridone and the use of them Derivatives of pyridone and the use of them

2003-11-14

2010-11-02

Marschel, Ardin (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S327000

Reexamination Certificate

active

07825133

ABSTRACT:
The present invention provides N-substituted-2(1H) pyridones or the pharmaceutical acceptable salts thereof, and the pharmaceutical preparations containing the compounds. The compounds of the present invention can be used to treat various fibrotic diseases effectively, e.g., hepatic fibrosis.

REFERENCES:
patent: 3839346 (1974-10-01), Gadekar
patent: 4866078 (1989-09-01), Perrior et al.
patent: 5039807 (1991-08-01), Perrior et al.
patent: 5310562 (1994-05-01), Margolin
patent: 5716632 (1998-02-01), Margolin
patent: 5789426 (1998-08-01), Hanauske-Abel et al.
patent: 5939439 (1999-08-01), Anthony et al.
patent: 5962478 (1999-10-01), Margolin
patent: 6048823 (2000-04-01), Yamaguchi et al.
patent: 6090822 (2000-07-01), Margolin
patent: 6265349 (2001-07-01), Yamaguchi et al.
patent: 6294350 (2001-09-01), Peterson
patent: 6300349 (2001-10-01), Margolin
patent: 6492395 (2002-12-01), Scheiwe et al.
patent: 6956044 (2005-10-01), Margolin
patent: 7067540 (2006-06-01), Devadas et al.
patent: 2003/0216257 (2003-11-01), Sagasser et al.
patent: 2004/0058964 (2004-03-01), Devadas et al.
patent: 2006/0039931 (2006-02-01), Scheiwe
patent: 2006/0100249 (2006-05-01), Smith
patent: 2006/0110358 (2006-05-01), Hsu
patent: 2006/0167064 (2006-07-01), Seth
patent: 2006/0211694 (2006-09-01), Devadas et al.
patent: 2006/0276510 (2006-12-01), Abu-Shakra et al.
patent: 2006/0279709 (2006-12-01), Yamamoto
patent: 1386737 (2002-12-01), None
patent: 0 458 861 (1996-03-01), None
patent: 1 138 329 (2001-10-01), None
patent: 0 383 591 (2001-11-01), None
patent: 0 702 551 (2002-09-01), None
patent: 1 069 898 (2004-05-01), None
patent: 1 261 338 (2006-06-01), None
patent: WO 97/41830 (1997-11-01), None
patent: WO 00/44381 (2000-08-01), None
patent: WO 01/58448 (2001-08-01), None
patent: WO 2005/047256 (2005-05-01), None
patent: WO 2006/004100 (2006-01-01), None
patent: WO 2006/108354 (2006-10-01), None
patent: WO 2006/109876 (2006-10-01), None
Ansel et al, Pharmaceutical dosage forms and drug delivery systems, Seventh edition, pp. 87-92, Copyright 1999.
Worbel et al, J. Med. Chem., 1989, vol. 32(11): 2493-3000, abstract.
Patani et al (Chemical Reviews, 1996, vol. 96 (8), pp. 3147-3176.
Chin Pharm J. vol. 37, No. 4, Apr. 2002, Pu Han-Lin et al., “Protective effects of 2-ethyl3-hydroxy-6-phenylthio-4-(1H)-pyridinone on injured primary cultured rat hepatocytes induced by CCl4” pp. 267-271.
Pu et al., “Protective effects of 2-ethyl-3-hydroxy-6-phenylthio-4-(1H)-pyridinone on injured primary cultured rat hepatocytes induced by CCl4” 2002, Chin Pharm J. vol. 37(4): 267-271 (in Chinese with English abstract).

Affiliated with

Also associated with

Rating

Derivatives of pyridone and the use of them does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Derivatives of pyridone and the use of them, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of pyridone and the use of them will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4181091